Clinical Trial Update: Short Contact Protocols to Reduce Pain During 10% ALA Gel Red-light Photodynamic Therapy of Actinic Keratoses [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated short contact protocols to reduce pain during red-light photodynamic therapy with 10% ALA gel for actinic keratosis; results have been…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• 5-ALA gel (5-aminolevulinic acid) (5-aminolevulinic acid)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Actinic Keratosis | Phase 2 | Status: COMPLETED | Results posted: 2025-10-23